BioSpace News Archive

Business

Tech Innovator Weave Announces Company-Wide Executive-Coaching Initiative

Weave, the premier customer communication platform for small businesses, today announced a new initiative to provide executive coaching to every Weave employee

October 9, 2019
·
2 min read
Drug Development

Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial

RESILIENT Protocol captures Encyclopedic information from tumors and uses Artificial Intelligence (AI) to optimize treatments;

October 9, 2019
·
3 min read
Biotech Bay

Kaiser Permanente Commits $2.75 Million To Study Childhood Trauma and Its Impact on Total Health

New research effort builds upon landmark study with CDC and will provide additional insights on the most promising interventions and emerging innovations in addressing adverse childhood experiences

October 9, 2019
·
4 min read
Business

Concept Companies Breaks Ground on New Location for Lacerta Therapeutics in Alachua’s Copeland Park

Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company.

October 9, 2019
·
2 min read
Business

Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019

Sage Therapeutics announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and discuss recent business updates.

October 9, 2019
·
1 min read
Biotech Beach

Ionis’ Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results

Ionis Pharmaceuticals, Inc. announced that the company has been notified by its partner Bayer about the decision to advance IONIS-FXI-LRx following positive clinical results.

October 9, 2019
·
6 min read
Business

Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd

The Board of AdAlta Limited, is pleased to announce the appointment of experienced global pharmaceutical executive Dr Tim Oldham as Chief Executive Officer and Managing Director.

October 9, 2019
·
3 min read
Drug Development

Oncologie Announces First Patient Enrolled in Global Phase 2 Study of Bavituximab Plus KEYTRUDA® (Pembrolizumab) for Advanced Gastric or Gastroesophageal Cancer

The initiated study will further evaluate the antitumor activity, safety and tolerability of bavituximab plus KEYTRUDA® in a gastric cancer population

October 9, 2019
·
3 min read
Business

STAAR Surgical to Report Third Quarter Results on October 30, 2019

STAAR Surgical Company announced that it will release financial results for the third quarter ended September 27, 2019 on Wednesday, October 30, 2019 after the market close.

October 9, 2019
·
2 min read
Genetown

Corvia Medical’s Interatrial Shunt Device (IASD®) Receives Breakthrough Device Designation For Heart Failure

Corvia Medical, Inc. announced the US Food and Drug Administration has granted the company a Breakthrough Device designation for its InterAtrial Shunt Device for heart failure.

October 9, 2019
·
3 min read